Advertisement
News
Advertisement

FDA Approves Qualitest’s Dexamethasone Elixir

Wed, 05/18/2011 - 12:58pm

 

Qualitest Pharmaceuticals has announced that the FDA has approved dexamethasone elixir, USP, 0.5mg/ 5 mL and OrsythiaT Tablets (levonorgestrel and ethinyl estradiol tablets, USP, 0.1 mg/0.02 mg).

Dexamethasone elixir is used to treat a variety of conditions including endocrine disorders, rheumatic disorders, and collagen diseases. OrsythiaT Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

The total IMS sales for dexamethasone elixir, USP, 0.5mg/ 5 mL and OrsythiaT Tablets (levonorgestrel and ethinyl estradiol tablets, USP, 0.1 mg/0.02 mg)for the 12-months ended March 31, 2011 are $4 million and $100 million, respectively.

 

Topics

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading